P568 An open-label, multicenter, phase ib, pharmacokinetic...

Journal of Crohn's and Colitis 2020 / 01 Vol. 14; Iss. Supplement

P568 An open-label, multicenter, phase ib, pharmacokinetic (pk) and safety study of a fimh blocker, Sibofimloc (TAK-018/EB8018), in patients with Crohn’s disease (CD)

Reinisch, W, Hébuterne, X, Buisson, A, Schreiber, S, Desreumaux, P, Paillarse, J M, Bonny, C
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjz203.696
Date:
January, 2020
File:
PDF, 270 KB
english, 2020
Conversion to is in progress
Conversion to is failed